Skip to main content
Top
Published in: Diabetologia 6/2004

01-06-2004 | Article

Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells

Authors: N. M. Al-Rasheed, F. Meakin, E. L. Royal, A. J. Lewington, J. Brown, G. B. Willars, N. J. Brunskill

Published in: Diabetologia | Issue 6/2004

Login to get access

Abstract

Aims/hypothesis

Proinsulin C-peptide is generally believed to be inert without any appreciable biological functions. However, it has been shown to modulate a variety of cellular processes important in the pathophysiology of diabetic complications. We therefore investigated the ability of C-peptide to stimulate intracellular signalling pathways in kidney proximal tubular cells, the altered activation of which may possibly be related to the development of diabetic nephropathy.

Methods

Extracellular signal-regulated kinase (ERK) and Akt phosphorylation were evaluated by western blotting. ERK activity was measured by in vitro kinase assay. Intracellular Ca2+ was evaluated by confocal imaging. The membrane and cytosol-associated fractions of protein kinase C (PKC) isoforms were evaluated by western blotting. Proliferation was assessed by thymidine incorporation assay.

Results

Using the opossum proximal tubular kidney cell line as a model, we demonstrated that at high picomolar to low nanomolar concentrations, C-peptide stimulates extracellular signal-regulated mitogen-activated kinase (3.3±0.1-fold over basal at 3 minutes) and phosphatidylinositol 3-kinase (4.1±0.05-fold over basal at 5 minutes). ERK activation was attenuated by pre-treatment with a PKC inhibitor and abolished by pertussis toxin. Elevations of intracellular [Ca2+] are seen in response to 5 nmol/l C-peptide with consequent activation of PKC-α. Pre-treatment with pertussis toxin abolished PKC-α. C-peptide is also a functional mitogen in this cell type, stimulating significantly increased cell proliferation. Proliferation was attenuated by wortmannin and pertussis toxin pre-treatments. None of these effects is reproduced by scrambled C-peptide.

Conclusions/interpretation

This study provides evidence that C-peptide, within physiological concentration ranges, stimulates many signalling pathways in opossum kidney cells.
Literature
1.
go back to reference Steiner DF, Cunningham D, Spigelman L, Aten B (1967) Insulin biosynthesis: evidence for precursor. Science 157:697–700PubMed Steiner DF, Cunningham D, Spigelman L, Aten B (1967) Insulin biosynthesis: evidence for precursor. Science 157:697–700PubMed
2.
go back to reference Rubenstein A, Clark J, Melani F, Steiner D (1969) Secretion of proinsulin C-peptide by pancreatic beta cells and its circulation in blood. Nature 224:697–699 Rubenstein A, Clark J, Melani F, Steiner D (1969) Secretion of proinsulin C-peptide by pancreatic beta cells and its circulation in blood. Nature 224:697–699
3.
go back to reference Steiner DF (1978) On the role of the proinsulin C-peptide. Diabetes 27 [Suppl 1]:145–148 Steiner DF (1978) On the role of the proinsulin C-peptide. Diabetes 27 [Suppl 1]:145–148
4.
go back to reference Hoogwerf BJ, Bantle JP, Genslen HE (1986) Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 35:122–125CrossRefPubMed Hoogwerf BJ, Bantle JP, Genslen HE (1986) Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 35:122–125CrossRefPubMed
6.
go back to reference Wahren J, Ekberg K, Johansson J et al. (2000) Role of C-peptide in human physiology. Am Physiol Endocrinol Metab 278:E759–E768 Wahren J, Ekberg K, Johansson J et al. (2000) Role of C-peptide in human physiology. Am Physiol Endocrinol Metab 278:E759–E768
7.
go back to reference Johansson BL, Sjoberg S, Wahren J (1992) The influence of human C-peptide on renal function and glucose utilization in the type I (insulin-dependent) diabetic patients. Diabetologia 35:121–128PubMed Johansson BL, Sjoberg S, Wahren J (1992) The influence of human C-peptide on renal function and glucose utilization in the type I (insulin-dependent) diabetic patients. Diabetologia 35:121–128PubMed
8.
go back to reference Johansson BL, Kernell A, Sjoberg S, Wahren J (1993) Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77:976–981CrossRefPubMed Johansson BL, Kernell A, Sjoberg S, Wahren J (1993) Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77:976–981CrossRefPubMed
9.
go back to reference Johansson BL, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J (1996) C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 39:687–695PubMed Johansson BL, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J (1996) C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 39:687–695PubMed
10.
go back to reference Ekberg K, Brismar T, Johansson BL, Lindstrom P, Wahren J (2003) Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 52:536–541 Ekberg K, Brismar T, Johansson BL, Lindstrom P, Wahren J (2003) Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 52:536–541
11.
go back to reference Johansson BL, Wahren J, Pernow J (2003) C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism. Am J Physiol Endocrinol Metab 285:E864–E870PubMed Johansson BL, Wahren J, Pernow J (2003) C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism. Am J Physiol Endocrinol Metab 285:E864–E870PubMed
12.
go back to reference Hansen A, Johansson BL, Wahren J, Von Bibra H (2002) C-peptide exerts beneficial effects on myocardial blood function in patients with type 1 diabetes. Diabetes 51:3077–3082 Hansen A, Johansson BL, Wahren J, Von Bibra H (2002) C-peptide exerts beneficial effects on myocardial blood function in patients with type 1 diabetes. Diabetes 51:3077–3082
13.
go back to reference Ohtomo Y, Aperia A, Sahlgren B, Johansson BL, Wahren J (1996) C-peptide stimulates rat renal tubular Na+,K+-ATPase activity in synergism with neuropeptide Y. Diabetologia 39:199–205 Ohtomo Y, Aperia A, Sahlgren B, Johansson BL, Wahren J (1996) C-peptide stimulates rat renal tubular Na+,K+-ATPase activity in synergism with neuropeptide Y. Diabetologia 39:199–205
14.
go back to reference Ohtomo Y, Bergman T, Johansson BL, Jornvall H, Wahren J (1998) Differential effects of proinsulin C-peptide on Na+, K+-ATPase activity of renal tubule segments. Diabetologia 41:287–291PubMed Ohtomo Y, Bergman T, Johansson BL, Jornvall H, Wahren J (1998) Differential effects of proinsulin C-peptide on Na+, K+-ATPase activity of renal tubule segments. Diabetologia 41:287–291PubMed
15.
go back to reference Shafqat J, Juntti-Berggren L, Zhong Z et al. (2002) Proinsulin C-peptide and its analogues induce intracellular Ca+2 increase in human renal tubular cells. Cell Mol Life Sci 59:1185–1189CrossRef Shafqat J, Juntti-Berggren L, Zhong Z et al. (2002) Proinsulin C-peptide and its analogues induce intracellular Ca+2 increase in human renal tubular cells. Cell Mol Life Sci 59:1185–1189CrossRef
16.
go back to reference Tismaratos M, Roger F, Chabardes D et al. (2003) C-peptide stimulates Na+-K+-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 46:124–131 Tismaratos M, Roger F, Chabardes D et al. (2003) C-peptide stimulates Na+-K+-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 46:124–131
17.
go back to reference Kitamura T, Kimura K, Jung BD et al. (2001) Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss3T3 fibroblasts: requirement of protein kinase C, phosphoinositide3-kinase and pertussis toxin-sensitive G-protein. Biochem J 355:123–129CrossRefPubMed Kitamura T, Kimura K, Jung BD et al. (2001) Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss3T3 fibroblasts: requirement of protein kinase C, phosphoinositide3-kinase and pertussis toxin-sensitive G-protein. Biochem J 355:123–129CrossRefPubMed
18.
go back to reference Rigler R, Pramanik A, Jonasson P et al. (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 96:13318–13323PubMed Rigler R, Pramanik A, Jonasson P et al. (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 96:13318–13323PubMed
19.
go back to reference Pramanik A, Ekberg K, Zhong Z et al. (2001) C-peptide binding to human cell membranes: importance of Glu27. Biochem Biophys Res Commun 284:94–98PubMed Pramanik A, Ekberg K, Zhong Z et al. (2001) C-peptide binding to human cell membranes: importance of Glu27. Biochem Biophys Res Commun 284:94–98PubMed
20.
go back to reference Ziyadeh FN (1993) The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736–744PubMed Ziyadeh FN (1993) The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736–744PubMed
21.
go back to reference Mogensen CE, Andersen MJ (1973) Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22:706–712 Mogensen CE, Andersen MJ (1973) Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22:706–712
22.
go back to reference Seyer-Hansen K (1976) Renal hypertrophy in streptozotocin-diabetic rats. Clin Sci Mol Med 51:551–555 Seyer-Hansen K (1976) Renal hypertrophy in streptozotocin-diabetic rats. Clin Sci Mol Med 51:551–555
23.
go back to reference Ritz E, Stefanski A (1996) Diabetic nephropathy in type II diabetes. Am J Kidney Dis 27:167–197PubMed Ritz E, Stefanski A (1996) Diabetic nephropathy in type II diabetes. Am J Kidney Dis 27:167–197PubMed
24.
go back to reference Ibrahim HI, Hostetter TH (1997) Diabetic nephropathy. J Am Soc Nephrol 8:487–493PubMed Ibrahim HI, Hostetter TH (1997) Diabetic nephropathy. J Am Soc Nephrol 8:487–493PubMed
25.
go back to reference Wirta OR, Pasternack AI (1995) Glomerular filtration rate and kidney size in type 2 (non-insulin-dependent) diabetes mellitus. Clin Nephrol 44:1–7PubMed Wirta OR, Pasternack AI (1995) Glomerular filtration rate and kidney size in type 2 (non-insulin-dependent) diabetes mellitus. Clin Nephrol 44:1–7PubMed
26.
go back to reference Derubertis FR, Craven PA (1994) Activation of protein kinase C in glomerular cells in diabetes: mechanism and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1–8PubMed Derubertis FR, Craven PA (1994) Activation of protein kinase C in glomerular cells in diabetes: mechanism and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1–8PubMed
27.
go back to reference Craven PA, Patterson MC, Derubertis FR (1988) Role of enhanced arachidonate availability through the phospholipase A2 pathway in the mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 37:429–435PubMed Craven PA, Patterson MC, Derubertis FR (1988) Role of enhanced arachidonate availability through the phospholipase A2 pathway in the mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 37:429–435PubMed
28.
go back to reference Ziyadeh FN, Fumo P, Rodenberger CH, Kuncio GS, Neilson EG (1995) Role of protein kinase C and cyclic AMP/protein kinase A in high glucose-stimulated transcriptional activation of collagen α1 (IV) in glomerular mesangial cells. J Diabetes Complications 9:255–261CrossRefPubMed Ziyadeh FN, Fumo P, Rodenberger CH, Kuncio GS, Neilson EG (1995) Role of protein kinase C and cyclic AMP/protein kinase A in high glucose-stimulated transcriptional activation of collagen α1 (IV) in glomerular mesangial cells. J Diabetes Complications 9:255–261CrossRefPubMed
29.
go back to reference Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R (1997) Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46:847–853 Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R (1997) Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46:847–853
30.
go back to reference Koyama H, Goodpasture C, Miller M, Teplitl L, Riggs AD (1978) Establishment and characterization of a cell line from the American opossum (Didelphys virginiana). In Vitro 14:239–246PubMed Koyama H, Goodpasture C, Miller M, Teplitl L, Riggs AD (1978) Establishment and characterization of a cell line from the American opossum (Didelphys virginiana). In Vitro 14:239–246PubMed
31.
go back to reference Pollock AS, Warnock DG, Strewler G (1986) Parathyroid hormone inhibition of Na+-H+ antiporter activity in cultured renal cell line. Am J Physiol 250:F217–F225 Pollock AS, Warnock DG, Strewler G (1986) Parathyroid hormone inhibition of Na+-H+ antiporter activity in cultured renal cell line. Am J Physiol 250:F217–F225
32.
go back to reference Dixon R, Young K, Brunskill NJ (1999) Lysophosphatidic acid-induced calcium mobilization and proliferation in kidney proximal tubular cells. Am J Physiol 276:F191–F198 Dixon R, Young K, Brunskill NJ (1999) Lysophosphatidic acid-induced calcium mobilization and proliferation in kidney proximal tubular cells. Am J Physiol 276:F191–F198
33.
go back to reference Brunskill NJ, Cockcroft N, Nahorski S, Walls J (1996) Albumin endocytosis is regulated by heterotrimeric GTP-binding protein Gαi-3 in opossum kidney cells. Am J Physiol 271:F356–F364PubMed Brunskill NJ, Cockcroft N, Nahorski S, Walls J (1996) Albumin endocytosis is regulated by heterotrimeric GTP-binding protein Gαi-3 in opossum kidney cells. Am J Physiol 271:F356–F364PubMed
34.
go back to reference Dixon RJ, Brunskill NJ (1999) Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: Role of PI3-kinase and ERK. Kidney Int 56:2064–2075CrossRefPubMed Dixon RJ, Brunskill NJ (1999) Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: Role of PI3-kinase and ERK. Kidney Int 56:2064–2075CrossRefPubMed
35.
go back to reference Willars GB, Challiss RAJ, Stuart JA, Nahorski SR (1996) Contrasting effects of phorbol ester and agonist-mediated activation of protein kinase C on phosphoinositide and Ca2+ signalling in a human neuroblastoma. Biochem J 316:905–913PubMed Willars GB, Challiss RAJ, Stuart JA, Nahorski SR (1996) Contrasting effects of phorbol ester and agonist-mediated activation of protein kinase C on phosphoinositide and Ca2+ signalling in a human neuroblastoma. Biochem J 316:905–913PubMed
36.
go back to reference Wolf G, Ziyadeh FN (1999) Molecular mechanism of diabetic renal hypertrophy. Kidney Int 56:393–405CrossRefPubMed Wolf G, Ziyadeh FN (1999) Molecular mechanism of diabetic renal hypertrophy. Kidney Int 56:393–405CrossRefPubMed
37.
go back to reference Phillips AO, Steadman R (2002) Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol 17:247–252PubMed Phillips AO, Steadman R (2002) Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol 17:247–252PubMed
38.
go back to reference Dreyer M, Matthaei S, Kuhnau J, Rudiger HW (1986) Prolonged plasma half-life of insulin in patients with a genetic defect of high affinity binding sites. Horm Metab Res 18:247–249PubMed Dreyer M, Matthaei S, Kuhnau J, Rudiger HW (1986) Prolonged plasma half-life of insulin in patients with a genetic defect of high affinity binding sites. Horm Metab Res 18:247–249PubMed
39.
go back to reference Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH (1975) Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55:1278–1283PubMed Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH (1975) Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55:1278–1283PubMed
40.
go back to reference Faber OK, Hagen C, Binder C et al. (1978) Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 62:197–203PubMed Faber OK, Hagen C, Binder C et al. (1978) Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 62:197–203PubMed
41.
go back to reference Johansson J, Ekberg K, Shafqat J et al. (2002) Breakthroughs and views: molecular effects of proinsulin C-peptide. Biochem Biophys Res Commun 295:1035–1040CrossRefPubMed Johansson J, Ekberg K, Shafqat J et al. (2002) Breakthroughs and views: molecular effects of proinsulin C-peptide. Biochem Biophys Res Commun 295:1035–1040CrossRefPubMed
42.
go back to reference Efendiev R, Bertorello AM, Pedemonte CH (1999) PKC-β and PKC-ζ mediate opposing effects on proximal tubule Na+, K+-ATPase activity. FEBS Lett 456:45–48CrossRefPubMed Efendiev R, Bertorello AM, Pedemonte CH (1999) PKC-β and PKC-ζ mediate opposing effects on proximal tubule Na+, K+-ATPase activity. FEBS Lett 456:45–48CrossRefPubMed
43.
go back to reference Ido Y, Vindigni A, Chang K et al. (1997) Prevention of vascular and renal dysfunction in diabetic rats by C-peptide. Science 277:563–566PubMed Ido Y, Vindigni A, Chang K et al. (1997) Prevention of vascular and renal dysfunction in diabetic rats by C-peptide. Science 277:563–566PubMed
44.
go back to reference Crespo P, Xu N, Simonds WF, Gutkind JS (1994) Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits. Nature 369:418–420PubMed Crespo P, Xu N, Simonds WF, Gutkind JS (1994) Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits. Nature 369:418–420PubMed
45.
46.
go back to reference Bucher K (2000) The role of protein kinase C in the regulation of cell growth and in signalling to the cell nucleus. J Cancer Res Clin Oncol 126:1–11PubMed Bucher K (2000) The role of protein kinase C in the regulation of cell growth and in signalling to the cell nucleus. J Cancer Res Clin Oncol 126:1–11PubMed
47.
go back to reference Marte BM, Downward J (2001) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22:355–358 Marte BM, Downward J (2001) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22:355–358
48.
go back to reference Li ZG, Zhang W, Sima AA (2003) C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SY5Y cells. Diabetes Metab Res Rev 19:375–385CrossRefPubMed Li ZG, Zhang W, Sima AA (2003) C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SY5Y cells. Diabetes Metab Res Rev 19:375–385CrossRefPubMed
49.
go back to reference Li ZG, Qiang X, Sima AA, Grunberger G (1997) C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts. Biochem Biophys Res Commun 280:615–619CrossRef Li ZG, Qiang X, Sima AA, Grunberger G (1997) C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts. Biochem Biophys Res Commun 280:615–619CrossRef
50.
go back to reference Grunberger G, Qiang X, Li Z et al. (2001) Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 44:1247–1257PubMed Grunberger G, Qiang X, Li Z et al. (2001) Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 44:1247–1257PubMed
Metadata
Title
Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells
Authors
N. M. Al-Rasheed
F. Meakin
E. L. Royal
A. J. Lewington
J. Brown
G. B. Willars
N. J. Brunskill
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1404-9

Other articles of this Issue 6/2004

Diabetologia 6/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.